These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Patient heterogeneity in clinical trials. Simon R Cancer Treat Rep; 1980; 64(2-3):405-10. PubMed ID: 7407777 [TBL] [Abstract][Full Text] [Related]
4. [The measurement parameters and statistical analysis of therapeutic study]. Zhou ZT; Yao H Shanghai Kou Qiang Yi Xue; 2004 Aug; 13(4):241-5. PubMed ID: 15349653 [TBL] [Abstract][Full Text] [Related]
5. Strategies for designing clinical trials for oligonucleotide therapeutics. Wacheck V Drug Discov Today; 2004 Nov; 9(21):918-23. PubMed ID: 15501726 [TBL] [Abstract][Full Text] [Related]
6. Unbiased assessment of treatment effects on disease recurrence and survival in clinical trials. Haybittle J Stat Med; 1983; 2(3):415-6. PubMed ID: 6648155 [No Abstract] [Full Text] [Related]
7. [Therapeutic studies. Provisional evaluation and early termination]. Köpcke W MMW Munch Med Wochenschr; 1982 May; 124(18):441-3. PubMed ID: 6808365 [No Abstract] [Full Text] [Related]
8. [Demonstration of a similarity of effect among several therapies: technics and value in medical decision-making]. Lacaine F; Rodary C; Flamant R Gastroenterol Clin Biol; 1981; 5(6-7):599-603. PubMed ID: 7250612 [No Abstract] [Full Text] [Related]
9. New methodology in clinical trials. Healy MJ Biometrics; 1978 Dec; 34(4):709-12. PubMed ID: 749953 [No Abstract] [Full Text] [Related]
10. [How to assess the size of a clinical trial?]. Paesmans M Rev Mal Respir; 1994; 11(6):547-57. PubMed ID: 7831504 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of therapeutic effectiveness. Methodological analysis]. Strauss E AMB Rev Assoc Med Bras; 1982; 28(7-8):182-7. PubMed ID: 6984948 [No Abstract] [Full Text] [Related]
12. Translational experimental therapeutics: The translation of laboratory-based discovery into disease-related therapy. Kieburtz K; Olanow CW Mt Sinai J Med; 2007 Apr; 74(1):7-14. PubMed ID: 17516559 [TBL] [Abstract][Full Text] [Related]
13. [Case number estimation and in-between evaluation]. Neiss A; Köpcke W; Uberla KK Internist (Berl); 1982 Apr; 23(4):195-200. PubMed ID: 7045021 [No Abstract] [Full Text] [Related]
14. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience. Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176 [TBL] [Abstract][Full Text] [Related]
16. [Assessment of the course of a disease in the therapeutic comparison]. Horbach L Arzneimittelforschung; 1974 Jul; 24(7):1001-4. PubMed ID: 4408031 [No Abstract] [Full Text] [Related]
17. [Use of standardization processes in the evaluation of therapeutic comparative groups]. Horbach L Arzneimittelforschung; 1967 Oct; 17(10):1279-88. PubMed ID: 5632878 [No Abstract] [Full Text] [Related]
18. Sequential clinical trials for normal variates using interval composite hypotheses. Lachin JM Biometrics; 1981 Mar; 37(1):87-101. PubMed ID: 7248445 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of therapeutic results and the concept of clinical trial]. Tsujii H; Irie G Gan No Rinsho; 1987 Mar; Spec No():191-8. PubMed ID: 3298713 [No Abstract] [Full Text] [Related]
20. [Freedom and responsibility of the research physician]. Laufs A Z Kardiol; 1993; 82 Suppl 5():1-6. PubMed ID: 8154147 [No Abstract] [Full Text] [Related] [Next] [New Search]